Investors

Modus Therapeutics’s key shareholder is KDev Investments AB, which is owned by Karolinska Development AB (Nasdaq Stockholm: KDEV) and Rosetta Capital. Other shareholders are The Foundation for Baltic and European Studies (Östersjöstiftelsen) and Praktikerinvest PE AB.

Read more about us

KDev Investments AB

The major investor in Modus Therapeutics is KDev Investments AB, a company jointly owned by Karolinska Development AB and Rosetta Capital.

Karolinska Development AB

Karolinska Development (KD) invests in new innovative treatments for life-threatening diseases

Rosetta Capital Ltd

Rosetta Capital – Unlocking value in the life science sector.

The Foundation for Baltic and European Studies (Östersjöstiftelsen)

The Foundation for Baltic and East European Studies (Östersjöstiftelsen, ÖSS) was founded by the Swedish Government in 1994. Its mission is to support research and doctoral studies, as well as the academic infrastructure at Södertörn University.

Praktikerinvest PE AB

Praktikerinvest is an investment company within the Praktikertjänst Group, Sweden’s biggest provider of private health and dental care, owned and run by dentists, doctors and other therapists.